AI-driven Therapies Deep Genomics leverages AI technology to develop life-saving genetic therapies, presenting opportunities for partnerships with healthcare providers looking to enhance treatment options.
Cutting-edge RNA Biology With the recent launch of BigRNA, an AI foundation model for uncovering RNA biology and therapeutics, Deep Genomics positions itself as a leader in cutting-edge research, offering collaboration opportunities for pharmaceutical companies seeking innovative solutions.
Executive Leadership Change The appointment of Brian O'Callaghan as CEO brings fresh perspectives and potential strategic shifts to Deep Genomics, creating an opportunity for service providers specializing in executive coaching or organizational consultancy.
$180M Funding With significant funding amounting to $180 million, Deep Genomics has the financial backing to support extensive research and development initiatives, making it an attractive target for investment firms looking to diversify their portfolio in the biotechnology sector.
Strategic Investments Deep Genomics' past investments in companies like Clearco showcase a proactive approach to partnerships and acquisitions, signaling potential joint venture opportunities for startups or firms seeking collaboration with a well-established player in the biotech industry.
$50M$100M
$10M
$10M$50M
$10M
$10M$50M
$10M
$10M$50MDeep Genomics uses 8 technology products and services including Zendesk, Jamf, TensorFlow, and more. Explore Deep Genomics's tech stack below.
| Deep Genomics Email Formats | Percentage |
| First@deepgenomics.com | 82% |
| First.Last@deepgenomics.com | 11% |
| Last@deepgenomics.com | 7% |
Biotechnology ResearchToronto, Canada51-200 Employees
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
Company Overview
Media & News
Funding & FinancialsDeep Genomics has raised a total of $180M of funding over 6 rounds. Their latest funding round was raised on Jul 28, 2021 in the amount of $180M.
Deep Genomics's revenue is in the range of $10M$50M
Funding & FinancialsDeep Genomics has raised a total of $180M of funding over 6 rounds. Their latest funding round was raised on Jul 28, 2021 in the amount of $180M.
Deep Genomics's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com